London, UK; Brentwood, TN, US; 4 June 2007 - Protherics PLC ("Protherics" or the
"Company"), the international biopharmaceutical company focused on critical care
and cancer, announces that, on 1 June 2007, a notification of interest in the
ordinary share capital of the Company was received from Aviva plc as follows:
